Since the E1A gene is essential for efficient adenoviral replication, replacing the native E1A promoter with a cancer-specific promoter leads to selective E1A expression, resulting in much higher levels of viral replication in cancer cells than in normal cells [61,79,80,81,82,83]. The gene discussed is DHTKD1; the disease is cancer.